Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
Public ClinicalTrials.gov record NCT04652570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2a Study of VB119 in Adult Subjects With Primary Membranous Nephropathy
Study identification
- NCT ID
- NCT04652570
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Tenet Medicines
- Industry
- Enrollment
- 6 participants
Conditions and interventions
Conditions
Interventions
- VB119 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2021
- Primary completion
- Nov 20, 2023
- Completion
- Aug 14, 2024
- Last update posted
- Feb 11, 2026
2021 – 2024
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Reserach Site | Los Angeles | California | 91324 | — |
| Clinical Research Site | Albany | New York | 12209 | — |
| Clinical Research Site | Bethlehem | Pennsylvania | 18017 | — |
| Clinical Research Site | Dallas | Texas | 75208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04652570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04652570 live on ClinicalTrials.gov.